Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial

Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:28:41.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a significant update in the dosage of intravenous tenecteplase being administered to patients with acute ischemic stroke in the clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:26.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value for Participation Criteria has been updated to provide detailed eligibility criteria for patients with acute ischemic stroke, including age and specific medical conditions. This change offers more specific information about the inclusion and exclusion criteria for the study.
    Difference
    12%
    Check dated 2024-05-22T21:12:12.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:35:56.000Z thumbnail image

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.